SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-22-136754
Filing Date
2022-05-02
Accepted
2022-05-02 16:09:01
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A d342375ddefa14a.htm DEFA14A 10545
2 GRAPHIC g342375page002.jpg GRAPHIC 286761
3 GRAPHIC g342375page003.jpg GRAPHIC 168492
  Complete submission text file 0001193125-22-136754.txt   639015
Mailing Address 7000 SHORELINE COURT SUITE 275 SOUTH SAN FRANCISCO CA 94080
Business Address 7000 SHORELINE COURT SUITE 275 SOUTH SAN FRANCISCO CA 94080 415-798-8589
Tempest Therapeutics, Inc. (Filer) CIK: 0001544227 (see all company filings)

IRS No.: 451472564 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-35890 | Film No.: 22881973
SIC: 2834 Pharmaceutical Preparations